WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH.

导出 OA

翻译打印收藏纠错

作者： Ruth,Kirschner-Hermanns ^[1] ; Petra,Funk ^[2] ; Nadine,Leistner ^[3]

作者单位： Urology/Neuro-Urology, University Clinic Friedrich-Wilhelms-University Bonn and Neurologic Rehabilitation Center 'Godeshoehe' e.V., Venusberg-Campus 1, Gebäude 22, Bonn, 53127, Germany. ^[1] Dr. Willmar Schwabe GmbH & Co KG, Clinical Research Department, Karlsruhe, Germany. ^[2] University Clinic, Rheinische Friedrich-Wilhelms-University - Clinic of Urology/Neuro-Urology Bonn, Germany. ^[3]

关键词 I-PSS LUTS benign prostatic hyperplasia efficacy sabal extract tolerability urtica extract

DOI 10.1177/1756287219879533

PMID 31656534

发布时间 2022-04-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in urology

1756287219879533页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH.

Therapeutic advances in urology

相似文献

Therapeutic advances in urology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH.

Therapeutic advances in urology

相似文献

Therapeutic advances in urology

相关期刊

检索历史清除